About us
HAO Capital is a China-focused Private Equity firm with offices in Beijing, Hong Kong and Kunming. Founded in 2006, the firm manages total assets in excess of US$600 million across four funds:
- HAO Fund I
- HAO Fund II
- HAO Auxiliary Fund
- HAO RMB Fund
Our skilled and diverse team has wide ranging experience across many fields including investment, legal, capital markets, cross-border M&A and operational management.
Recent News
- Buchang announces dividend for FY2018 August 15, 2019
- TCL Healthcare enters the High Dose Rate Brachytherapy solutions market in China August 1, 2019
- AMS receives approval to start clinical trials for 18F-NaF July 17, 2019
- Daijia helped the 2nd Hospital of Jilin University pass the “Interconnected Hospital Information Test” June 21, 2019
- Buchang announces dividend for 2017 June 30, 2018
- Daijia completes Series A-2 fundraising round June 30, 2017
- Buchang announces dividend for 2016 May 30, 2017
- AMS acquired by A-share listed Dongcheng May 25, 2017